BioSpace News Archive

HedgePath Pharmaceuticals, Inc. (OTCQB: HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced today that it has signed an exclusive option agreement with the University of Connecticut (UConn) related to patents and patent applications covering certain chemical analogues of the Food and Drug Administration (FDA) approved anti-fungal drug itraconazole.

Jazz Pharmaceuticals plc announced that data from the pivotal Phase 3 study of Vyxeos® (daunorubicin and cytarabine) liposome for injection compared to standard of care cytarabine and daunorubicin (7+3) were published online in the Journal of Clinical Oncology.

The FDA has just-issued a Biosimilar Action Plan (BAP) that considers most of the recommendations made by Sarfaraz Niazi.

Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on the new Health and Human Services (HHS) proposal pending at the Office of Management and Budget (OMB)

ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that it is launching a Heroes for Life™ program to honor “unexpected heroes” who have helped save the life of a sudden cardiac arrest (SCA) victim with a ZOLL AED and recognize SCA survivors.

Blue Cross and Blue Shield of Kansas City (Blue KC) introduced Well Stocked, a new community impact initiative focused on increasing access to nutritious food in underserved areas in Kansas City.

Quo-Lab meets strict international quality targets – confirming it fit for purpose for diabetes testing.

False Claims Lawsuit reveals sales of embolic device for uses other than those approved by the Food and Drug Administration.

The FCA Family Health and Wellness Center, powered by St. Vincent, established to serve FCA employees and their families, totals more than 22,000 health care members

The Biotechnology Innovation Organization (BIO) today presented Dr. Larry Walker, co-editor in chief for the journal “Industrial Biotechnology,” with the third annual BIO Leadership and Legacy Award in Industrial Biotechnology and Agriculture.